About
I am a scientist specializing in immunology, with an MSc in biochemistry and a PhD in biomedical sciences. My scientific career has focused on understanding the mechanisms that regulate the immune response in various pathological contexts, ranging from autoimmunity to cancer.
Currently, I am a postdoctoral researcher at CIML, where I explore the interactions between metabolism, epigenetics and immunity in glioblastoma and acute myeloid leukemia. My projects mainly aim to study how the crosstalk between the tumor microenvironment and immune cells shapes the antitumor response, from cell differentiation to function, with the aim of identifying metabolic targets that could help predict response to therapies and disease progression.
Projects
Duration: 2021–2025.Partners & funding amounts: APHM/La Timone (E. Tabouret); amount for team: 325 k€.Responsibilities: PI–coordinator (only beneficiary)Theme & content of […]
Bone marrow metabolic niches regulate hematopoiesis (MetaNiche, ANR-22-CE15-0015-02). Duration: 2023–2027 (42 months).Partners & funding amounts: Institut Curie (L. Perié), Institut […]
Full title & acronym: Biomarkers established to stratify sepsis long-term adverse effects to improve patients' survivorship (BEATsep).Duration: 2024–2029 (60 months).Partners […]
Anti-GD3 CAR-NK cells to overcome therapeutic resistance in glioblastoma (Caribbean). Type: National.Duration: 2025–2029 (48 months).Partners & funding amounts: INP-APHM (E. […]
Targeting intratumor metabolic heterogeneity in neuroblastoma to develop innovative treatments (IMAGINe) Type: National.Duration: 2024–2029 (48 months).Partners & funding amounts: CRCM […]
Targeting acute myeloid leukemia immunosuppressive microenvironment by combined IDO1 inhibition and PD-1 blockade Type: European.Duration: 2023–2027 (36 months).Partners & funding […]
South-Research On Cancer for Kids. INCA Pediacriex (France) Type: National (integrated cancer site).Full title & acronym: South-Research On Cancer for […]